Human induced pluripotent stem cell–derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis-Reference-Cited by-同舟云学术

Human induced pluripotent stem cell–derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis

Published:2019-07-25 Issue:14 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Povero Davide,Pinatel Eva M.^ORCID,Leszczynska Aleksandra,Goyal Nidhi P.,Nishio Takahiro,Kim Jihoon,Kneiber David^ORCID,de Araujo Horcel Lucas^ORCID,Eguchi Akiko,Ordonez Paulina M.,Kisseleva Tatiana,Feldstein Ariel E.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/125652/files/pdf

Reference45 articles.

1. Is it time to change NAFLD and NASH nomenclature?

2. Predicting the future burden of NAFLD and NASH

3. Nonalcoholic steatohepatitis: risk factors and diagnosis

4. Use of differentiated pluripotent stem cells in replacement therapy for treating disease

5. Advancing stem cell therapy from bench to bedside: lessons from drug therapies;Srijaya;J Transl Med,2014

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis;Journal of Nanobiotechnology;2024-09-05

2. Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in Mice;International Journal of Nanomedicine;2024-08

3. Extracellular vesicles derived from “serum and glucose” deprived HUCMSCs promoted skin wound healing through enhanced angiogenesis;Molecular and Cellular Biochemistry;2024-07-05

4. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18

5. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis;Molecular Biology Reports;2024-06-14